![Tsuyoshi Chiwata](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tsuyoshi Chiwata
Direktor/Vorstandsmitglied bei Aramis Biosciences, Inc.
Ursprung des Netzwerks ersten Grades von Tsuyoshi Chiwata
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Aramis Biosciences, Inc.
![]() Aramis Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company based in Medfield, MA. Aramis Biosciences is committed to developing disease-modifying therapy for ocular surface disease, starting with dry eye disease. The company's lead product candidate, A197, is a novel, first-in-class, topical immunomodulatory agent currently in a phase II clinical proof of concept for the treatment of dry eye disease. The company was founded in 2018 by Sunil Chauhan, Reza Dana, and the CEO is David S. Tierney. Aramis Biosciences was founded by leading experts in the fields of corneal disorders, ocular inflammation, and immunology from the Schepens Eye Research Institute of Mass Eye and Ear and the Department of Ophthalmology at Harvard Medical School, with support from Safar Partners, Dompé Farmaceutici S.p.A., and a leader in ophthalmic pharmaceuticals.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Tsuyoshi Chiwata
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Roberts Pharmaceutical Corp.
![]() Roberts Pharmaceutical Corp. Pharmaceuticals: OtherHealth Technology Roberts Pharmaceutical Corp. provides pharmaceutical products. It offers medicines for cardiovascular, gynecology. The company is headquartered in Eatontown, NJ. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Valera Pharmaceuticals, Inc.
![]() Valera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Valera Pharmaceuticals, Inc. develops and commercializes products for the treatment of urology and endocrine conditions, diseases and disorders. The Company was founded in 1972 and is located in Cranbury, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
Signet Healthcare Partners LLC
![]() Signet Healthcare Partners LLC Investment ManagersFinance Signet Healthcare Partners LLC (Signet Healthcare Partners) is a private equity/venture capital subsidiary of Sanders Morris Harris Group Private Equity founded in 1998. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
CATALYST PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Elan Pharmaceuticals, LLC
![]() Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Inanovate, Inc.
![]() Inanovate, Inc. Information Technology ServicesTechnology Services Inanovate, Inc. provides protein screening services. Its product include Bio-ID, a multiplexed protein quantification platform which, in real-time, measures protein concentrations from matrices. The company was founded by David Alexander Ure and David J Arslanian in 2007 and is headquartered in Sioux Falls, SD. | Information Technology Services | Director/Board Member | |
OCULAR THERAPEUTIX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Icon Bioscience, Inc.
![]() Icon Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Icon Bioscience, Inc. develops and markets ophthalmic pharmaceuticals. It develops specialty pharmaceuticals targeting ophthalmic indications including macular edema, glaucoma, age-related macular degeneration and cataract surgery. The firm's pipeline includes IBI-10090, IBI-20089, IBI-60089, and IBI-80090. The company was founded by Vernon G. Wong and is headquartered in Newark, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
ZEVRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
VIATAR CTC SOLUTIONS INC. | Medical Specialties | Director/Board Member | |
Bimeda, Inc.
![]() Bimeda, Inc. Pharmaceuticals: MajorHealth Technology Bimeda, Inc. manufactures veterinary pharmaceuticals and animal health care products. The company has operations in the United Kingdom, Canada, the United States, Mexico, and Ireland. The firm was founded in 1997 and is headquartered in Oakbrook, IL | Pharmaceuticals: Major | Director/Board Member | |
Williams College | College/University | Undergraduate Degree | |
APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
Royal College of Surgeons | College/University | Doctorate Degree | |
Biovail Technologies Ltd. | President | ||
Oceana Therapeutics, Inc.
![]() Oceana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oceana Therapeutics, Inc. manufactures pharmaceuticals and medical devices. It develops and commercializes therapeutics with a focus on colorectal, gastroenterology, and urological diseases. The firm provides Deflux that is used for the treatment of Vesicoureteral reflux, urological conditions and Solesta which is used for the treatment of fecal incontinence. The company was founded in 2008 and is headquartered in Edison, NJ. | Pharmaceuticals: Major | Founder | |
New England Eye Center
![]() New England Eye Center Medical/Nursing ServicesHealth Services New England Eye Center offers a full range of ophthalmology services. It specializes in cornea, external disease, and cataracts; glaucoma; oculoplastics; pediatric ophthalmology; retinal and macular diseases; vision rehabilitation; uveitis and immunology; pediatric optometry; and vision correction surgery. The company is headquartered in Boston, MA. | Medical/Nursing Services | Corporate Officer/Principal | |
Caspian Private Equity LLC
![]() Caspian Private Equity LLC Investment ManagersFinance Caspian Private Equity LLC is a private equity firm founded in 2008.The firm is headquartered in New York. | Investment Managers | Chief Executive Officer | |
Kellogg School of Management | College/University | Masters Business Admin | |
Feinberg School of Medicine | College/University | Doctorate Degree | |
Tufts University School of Medicine | College/University | Corporate Officer/Principal | |
University of Florida College of Medicine | College/University | Corporate Officer/Principal | |
Palvella Therapeutics, Inc.
![]() Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | Biotechnology | Director/Board Member | |
Safar Partners LLC
![]() Safar Partners LLC Investment ManagersFinance Safar Partners LLC (Safar Partners) is a venture capital firm founded in 2019 by Nader Motamedy. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Founder | |
Aurion Biotech, Inc.
![]() Aurion Biotech, Inc. Medical/Nursing ServicesHealth Services Aurion Biotech, Inc. is a clinical-stage biotech company with offices in multiple locations. Aurion Biotech has initiated clinical trials in the US in 2023. The company is based in Seattle, WA. The company's mission is to restore vision to millions of patients with life-changing regenerative therapies. Aurion Biotech has received the prestigious Prix Galien award for best start-up in biotech. The company's first candidate is an off-the-shelf, clinically validated cell therapy for corneal care, which has received regulatory approval. The company is privately held and backed by leading investors, including Deerfield, Alcon, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures. Greg Kunst has been the CEO of the company since 2021. | Medical/Nursing Services | President | |
Pharma Two B Ltd.
![]() Pharma Two B Ltd. Pharmaceuticals: GenericHealth Technology Pharma Two B Ltd. operates as a biopharmaceutical company which focuses on developing treatments for Parkinson’s disease. The firm focuses on Fixed-Dose-combinations of two or more drugs with synergistic effects, providing clinical value and regulatory pathways. The company was founded by Ehud Marom and Nurit Livnah in December 2007 and is headquartered in Rehovot, Israel. | Pharmaceuticals: Generic | Chief Executive Officer |
Statistik
International
Vereinigte Staaten | 31 |
Irland | 2 |
Israel | 2 |
Sektoral
Health Technology | 19 |
Consumer Services | 7 |
Finance | 5 |
Health Services | 3 |
Technology Services | 2 |
Operativ
Director/Board Member | 15 |
President | 7 |
Chief Executive Officer | 6 |
Corporate Officer/Principal | 6 |
Chief Tech/Sci/R&D Officer | 4 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
David Tierney | 19 |
Michael H. Goldstein | 12 |
Nader Motamedy | 4 |
Sunil Chauhan | 1 |
- Börse
- Insiders
- Tsuyoshi Chiwata
- Unternehmensverbindungen